Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy
Objective: Despite significant advances in understanding hypertrophic cardiomyopathy (HCM) in recent years, there is a need to improve risk stratification for patients at high risk of adverse outcomes. The relationship between inflammation and disease severity in HCM patients is known. Recently, a n...
Saved in:
| Main Authors: | Levent PAY, Ahmet Cagdas YUMURTAS, Seyda DERELI, Tugba CETIN, Hikmet KADI, Tufan CINAR, Mert Ilker HAYIROGLU |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2024-12-01
|
| Series: | Medeniyet Medical Journal |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-96266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
by: Jan M. Federspiel, et al.
Published: (2024-11-01) -
Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by: Ewelina Młynarska, et al.
Published: (2024-11-01) -
Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01) -
Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01) -
The D‐HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathy
by: G. Domain, et al.
Published: (2024-12-01)